MetLife Gets Positive Feedback from Analysts

MetLife, Inc. (NYSE:MET) is among the 9 Best Life Insurance Stocks to Buy Now.  MetLife Gets Positive Feedback from Analysts ssguy/Shutterstock.com As of December 5, analyst opinions on MetLife, Inc. (NYSE:MET) are modestly positive, with more than 60% of analysts assigning it a Buy or equivalent rating. The consensus 1-year median price target is $93, implying over 18%-19% upside. MetLife, Inc. (NYSE:MET) announced Q4 2025 preferred stock dividends across three series, according to Business Wire on No ...